{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T23:48:02Z","timestamp":1782172082953,"version":"3.54.5"},"reference-count":81,"publisher":"Georg Thieme Verlag KG","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["GR 2232\/9-1"],"award-info":[{"award-number":["GR 2232\/9-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","award":["INV-090519"],"award-info":[{"award-number":["INV-090519"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"abstract":"<jats:p>Antibody-mediated immune responses against platelet factor 4 (PF4) underlie a spectrum of rare but severe thromboinflammatory disorders, including heparin-induced thrombocytopenia (HIT), autoimmune HIT variants, vaccine-induced immune thrombocytopenia and thrombosis (VITT), and VITT-like syndromes. Despite differences in triggering factors and antibody-binding requirements, these conditions share a common pathogenic mechanism in which anti-PF4\u2013IgG immune complexes engage platelet Fc\u03b3RIIa, thereby triggering platelet activation, procoagulant transformation, and amplification of immunothrombosis. Experimental models have been instrumental in defining the molecular and cellular basis of anti-PF4 immunothrombosis. Platelet-centric in vitro assays and whole-blood systems established Fc\u03b3RIIa-dependent platelet activation as a central effector mechanism and revealed functional heterogeneity among anti-PF4 antibodies. Flow-based vascular models further incorporate shear stress and endothelial interfaces, enabling analysis of thrombus formation under near-physiological conditions. In vivo, passive antibody transfer models in humanized mice expressing human PF4 and Fc\u03b3RIIa reproduce key clinical features, including thrombocytopenia and thrombosis, and have enabled mechanistic and therapeutic studies. Despite these advances, important conceptual gaps remain. Most existing models focus on the effector phase of disease. Conversely, active immunization models can induce anti-PF4 antibodies but rarely reproduce the downstream thrombotic phenotype. As a result, the mechanisms linking antigen formation, innate immune activation, B cell recruitment, and acquisition of pathogenic antibody function remain incompletely understood. Developing integrated experimental systems that connect immune initiation with Fc\u03b3RIIa-dependent effector pathways will be essential to advance mechanistic insight, improve therapeutic strategies, and establish predictive preclinical models to assess the risk of anti-PF4 antibody induction during vaccine development.<\/jats:p>","DOI":"10.1055\/a-2870-6827","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T22:57:58Z","timestamp":1781564278000},"source":"Crossref","is-referenced-by-count":0,"title":["Experimental Models of Anti-PF4 Immunothrombosis: Mechanistic Insights, Translational Value, and Unmet Needs"],"prefix":"10.1055","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1221-1118","authenticated-orcid":false,"given":"Emily","family":"Leitner","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsmedizin Greifswald, Mecklenburg Vorpommern, Germany","place":["Greifswald"],"department":["Institut f\u00fcr Transfusionsmedizin"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8343-7336","authenticated-orcid":false,"given":"Andreas","family":"Greinacher","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsmedizin Greifswald, Mecklenburg Vorpommern, Germany","place":["Greifswald"],"department":["Institut f\u00fcr Transfusionsmedizin"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Wesche","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsmedizin Greifswald, Mecklenburg Vorpommern, Germany","place":["Greifswald"],"department":["Institut f\u00fcr Transfusionsmedizin"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsmedizin Greifswald, Mecklenburg Vorpommern, Germany","place":["Greifswald"],"department":["Institut f\u00fcr Transfusionsmedizin"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"issue":"01","key":"ref1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/hematology.2023000503","article-title":"Thrombotic anti-PF4 immune disorders: HIT, VITT, and beyond","volume":"2023","author":"A Greinacher","year":"2023","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"issue":"02","key":"ref2","doi-asserted-by":"crossref","first-page":"102729","DOI":"10.1016\/j.rpth.2025.102729","article-title":"Anti-platelet factor 4 immunothrombosis\u2014not just heparin and vaccine triggers","volume":"9","author":"L M\u00fcller","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"key":"ref3","volume-title":"Heparin-Induced Thrombocytopenia","author":"D Nicolas","year":"2026"},{"issue":"01","key":"ref4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-0034-1398381","article-title":"Heparin-induced thrombocytopenia in critically ill patients","volume":"41","author":"T E Warkentin","year":"2015","journal-title":"Semin Thromb Hemost"},{"issue":"11","key":"ref5","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1111\/jth.13813","article-title":"Autoimmune heparin-induced thrombocytopenia","volume":"15","author":"A Greinacher","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"21","key":"ref6","doi-asserted-by":"crossref","first-page":"6921","DOI":"10.3390\/jcm12216921","article-title":"Autoimmune heparin-induced thrombocytopenia","volume":"12","author":"T E Warkentin","year":"2023","journal-title":"J Clin Med"},{"issue":"18","key":"ref7","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical features of vaccine-induced immune thrombocytopenia and thrombosis","volume":"385","author":"S Pavord","year":"2021","journal-title":"N Engl J Med"},{"issue":"05","key":"ref8","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/imj.15783","article-title":"Understanding vaccine-induced thrombotic thrombocytopenia (VITT)","volume":"52","author":"C Dix","year":"2022","journal-title":"Intern Med J"},{"issue":"06","key":"ref9","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJMc2307721","article-title":"Adenovirus-associated thrombocytopenia, thrombosis, and VITT-like antibodies","volume":"389","author":"T E Warkentin","year":"2023","journal-title":"N Engl J Med"},{"issue":"05","key":"ref10","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3324\/haematol.2021.280366","article-title":"Platelet-activating anti-PF4 antibodies mimic VITT antibodies in an unvaccinated patient with monoclonal gammopathy","volume":"107","author":"A Greinacher","year":"2022","journal-title":"Haematologica"},{"issue":"27","key":"ref11","doi-asserted-by":"crossref","first-page":"8361","DOI":"10.1021\/bi00193a025","article-title":"Crystal structure of recombinant human platelet factor 4","volume":"33","author":"X Zhang","year":"1994","journal-title":"Biochemistry"},{"issue":"02","key":"ref12","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1182\/blood-2013-01-478966","article-title":"Complex formation with nucleic acids and aptamers alters the antigenic properties of platelet factor 4","volume":"122","author":"M E Jaax","year":"2013","journal-title":"Blood"},{"issue":"16","key":"ref13","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1182\/blood-2012-06-434985","article-title":"Platelet factor 4 binding to lipid A of Gram-negative bacteria exposes PF4\/heparin-like epitopes","volume":"120","author":"K Krauel","year":"2012","journal-title":"Blood"},{"issue":"01","key":"ref14","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/0003-9861(85)90049-9","article-title":"The interaction of platelet factor four and glycosaminoglycans","volume":"240","author":"J Loscalzo","year":"1985","journal-title":"Arch Biochem Biophys"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"966754","DOI":"10.3389\/fmolb.2022.966754","article-title":"Evaluating the immunogenicity of heparin and heparin derivatives by measuring their binding to platelet factor 4 using biolayer interferometry","volume":"9","author":"Q Chen","year":"2022","journal-title":"Front Mol Biosci"},{"issue":"12","key":"ref16","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1016\/j.jtha.2023.08.020","article-title":"New insights into the binding of PF4 to long heparin oligosaccharides in ultralarge complexes using mass spectrometry","volume":"21","author":"D Shi","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"04","key":"ref17","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1182\/blood.2023021307","article-title":"Characterization of reverse-engineered anti-PF4 stereotypic antibodies derived from serum of patients with VITT","volume":"143","author":"J J Wang","year":"2024","journal-title":"Blood"},{"issue":"15","key":"ref18","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1182\/blood.2022016474","article-title":"Vaccine-induced immune thrombotic thrombocytopenia is mediated by a stereotyped clonotypic antibody","volume":"140","author":"J J Wang","year":"2022","journal-title":"Blood"},{"issue":"01","key":"ref19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1182\/blood.2021014588","article-title":"Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT","volume":"140","author":"A J Kanack","year":"2022","journal-title":"Blood"},{"issue":"7873","key":"ref20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-021-03744-4","article-title":"Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia","volume":"596","author":"A Huynh","year":"2021","journal-title":"Nature"},{"issue":"23","key":"ref21","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1182\/blood.2021013839","article-title":"The interaction between anti-PF4 antibodies and anticoagulants in vaccine-induced thrombotic thrombocytopenia","volume":"139","author":"A Singh","year":"2022","journal-title":"Blood"},{"issue":"03","key":"ref22","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.V72.3.925.bloodjournal723925","article-title":"Heparin-induced thrombocytopenia: laboratory studies","volume":"72","author":"J G Kelton","year":"1988","journal-title":"Blood"},{"issue":"01","key":"ref23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/MOH.0000000000000900","article-title":"Cellular contributions to the pathogenesis of anti-platelet factor 4 disorders","volume":"33","author":"J Treverton","year":"2026","journal-title":"Curr Opin Hematol"},{"issue":"39","key":"ref24","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1093\/eurheartj\/ehab506","article-title":"Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia","volume":"42","author":"S Holm","year":"2021","journal-title":"Eur Heart J"},{"issue":"01","key":"ref25","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s41467-019-09160-7","article-title":"Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia","volume":"10","author":"J Perdomo","year":"2019","journal-title":"Nat Commun"},{"issue":"S 01","key":"ref26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/ijlh.12993","article-title":"Laboratory diagnosis of heparin-induced thrombocytopenia","volume":"41","author":"T E Warkentin","year":"2019","journal-title":"Int J Lab Hematol"},{"issue":"06","key":"ref27","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1055\/s-0042-1758818","article-title":"Laboratory testing for heparin-induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia antibodies: a narrative review","volume":"49","author":"T E Warkentin","year":"2023","journal-title":"Semin Thromb Hemost"},{"issue":"10","key":"ref28","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1111\/j.1538-7836.2005.01560.x","article-title":"Activation of platelets by heparin-induced thrombocytopenia antibodies in the serotonin release assay is not dependent on the presence of heparin","volume":"3","author":"M M Prechel","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"08","key":"ref29","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.jtha.2023.04.034","article-title":"Investigation of anti-PF4 versus anti-PF4\/heparin reactivity using fluid-phase enzyme immunoassay for 4 anti-PF4 disorders: classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, vaccine-induced immune thrombotic thrombocytopenia, and spontaneous HIT","volume":"21","author":"T E Warkentin","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"06","key":"ref30","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1055\/s-0038-1646493","article-title":"A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia","volume":"66","author":"A Greinacher","year":"1991","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref31","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1055\/s-0037-1614536","article-title":"First workshop for detection of heparin-induced antibodies: validation of the heparin-induced platelet-activation test (HIPA) in comparison with a PF4\/heparin ELISA","volume":"81","author":"P Eichler","year":"1999","journal-title":"Thromb Haemost"},{"issue":"06","key":"ref32","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/ajh.24006","article-title":"The platelet serotonin-release assay","volume":"90","author":"T E Warkentin","year":"2015","journal-title":"Am J Hematol"},{"issue":"11","key":"ref33","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1111\/jth.15848","article-title":"Variable serotonin release assay pattern and specificity of PF4-specific antibodies in HIT, and clinical relevance","volume":"20","author":"J Rollin","year":"2022","journal-title":"J Thromb Haemost"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"14945","DOI":"10.1038\/ncomms14945","article-title":"Anti-platelet factor 4\/polyanion antibodies mediate a new mechanism of autoimmunity","volume":"8","author":"T H Nguyen","year":"2017","journal-title":"Nat Commun"},{"issue":"04","key":"ref35","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3390\/molecules22040617","article-title":"Functional assays in the diagnosis of heparin-induced thrombocytopenia: a review","volume":"22","author":"V Minet","year":"2017","journal-title":"Molecules"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"8277","DOI":"10.1038\/ncomms9277","article-title":"Atomic description of the immune complex involved in heparin-induced thrombocytopenia","volume":"6","author":"Z Cai","year":"2015","journal-title":"Nat Commun"},{"issue":"10","key":"ref37","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1161\/01.ATV.0000238350.89477.88","article-title":"Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies","volume":"26","author":"A Greinacher","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"02","key":"ref38","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/j.seminhematol.2022.03.003","article-title":"Laboratory testing for VITT antibodies","volume":"59","author":"T E Warkentin","year":"2022","journal-title":"Semin Hematol"},{"issue":"22","key":"ref39","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"A Greinacher","year":"2021","journal-title":"N Engl J Med"},{"issue":"10","key":"ref40","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/jth.13066","article-title":"Distinguishing between anti-platelet factor 4\/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia","volume":"13","author":"I Nazi","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"05","key":"ref41","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/bjh.14955","article-title":"Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies","volume":"179","author":"C Vayne","year":"2017","journal-title":"Br J Haematol"},{"issue":"26","key":"ref42","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1182\/blood.2021012064","article-title":"A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination","volume":"137","author":"S Handtke","year":"2021","journal-title":"Blood"},{"issue":"06","key":"ref43","first-page":"1322","article-title":"A modified PF4-dependent, CD62p expression assay selectively detects serotonin-releasing antibodies in patients suspected of HIT","volume":"114","author":"A Padmanabhan","year":"2015","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1182\/blood-2014-06-580894","article-title":"Heparin-independent, PF4-dependent binding of HIT antibodies to platelets: implications for HIT pathogenesis","volume":"125","author":"A Padmanabhan","year":"2015","journal-title":"Blood"},{"issue":"03","key":"ref45","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1055\/s-0038-1649842","article-title":"Characterization of the structural requirements for a carbohydrate based anticoagulant with a reduced risk of inducing the immunological type of heparin-associated thrombocytopenia","volume":"74","author":"A Greinacher","year":"1995","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref46","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1067\/mlc.2001.115525","article-title":"Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia\/thrombosis","volume":"138","author":"G P Visentin","year":"2001","journal-title":"J Lab Clin Med"},{"issue":"15","key":"ref47","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1182\/blood-2014-03-559518","article-title":"Binding of anti-platelet factor 4\/heparin antibodies depends on the thermodynamics of conformational changes in platelet factor 4","volume":"124","author":"M Kreimann","year":"2014","journal-title":"Blood"},{"issue":"12","key":"ref48","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1111\/jth.13516","article-title":"Heparin-induced multi-electrode aggregometry method for heparin-induced thrombocytopenia testing: communication from the SSC of the ISTH","volume":"14","author":"M C Morel-Kopp","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"06","key":"ref49","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3109\/09537104.2012.724736","article-title":"Heparin-induced multiple electrode aggregometry is a promising and useful functional tool for heparin-induced thrombocytopenia diagnosis: confirmation in a prospective study","volume":"24","author":"V Galea","year":"2013","journal-title":"Platelets"},{"issue":"11","key":"ref50","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1182\/bloodadvances.2021006698","article-title":"A novel flow cytometry procoagulant assay for diagnosis of vaccine-induced immune thrombotic thrombocytopenia","volume":"6","author":"C SM Lee","year":"2022","journal-title":"Blood Adv"},{"issue":"04","key":"ref51","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/jth.15650","article-title":"Measurement of procoagulant platelets provides mechanistic insight and diagnostic potential in heparin-induced thrombocytopenia","volume":"20","author":"C SM Lee","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref52","doi-asserted-by":"crossref","first-page":"5206","DOI":"10.1038\/s41467-022-32946-1","article-title":"NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia","volume":"13","author":"H HL Leung","year":"2022","journal-title":"Nat Commun"},{"issue":"18","key":"ref53","doi-asserted-by":"crossref","first-page":"e99445","DOI":"10.1172\/jci.insight.99445","article-title":"Neutrophil accumulation and NET release contribute to thrombosis in HIT","volume":"3","author":"K Gollomp","year":"2018","journal-title":"JCI Insight"},{"issue":"08","key":"ref54","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1182\/bloodadvances.2024014167","article-title":"Platelet spleen tyrosine kinase is a key regulator of anti-PF4 antibody-induced immunothrombosis","volume":"9","author":"J Zlamal","year":"2025","journal-title":"Blood Adv"},{"issue":"15","key":"ref55","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1182\/blood.2018881607","article-title":"Recognition of PF4-VWF complexes by heparin-induced thrombocytopenia antibodies contributes to thrombus propagation","volume":"135","author":"I Johnston","year":"2020","journal-title":"Blood"},{"issue":"12","key":"ref56","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1182\/bloodadvances.2024014165","article-title":"Endothelial cell activation enhances thromboinflammation in vaccine-induced immune thrombotic thrombocytopenia","volume":"9","author":"A Dupuy","year":"2025","journal-title":"Blood Adv"},{"issue":"05","key":"ref57","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/09537104.2017.1306042","article-title":"Flow chamber and microfluidic approaches for measuring thrombus formation in genetic bleeding disorders","volume":"28","author":"R M Schoeman","year":"2017","journal-title":"Platelets"},{"issue":"08","key":"ref58","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1182\/blood.V98.8.2442","article-title":"Heparin-induced thrombocytopenia\/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through FcgammaRIIA","volume":"98","author":"M P Reilly","year":"2001","journal-title":"Blood"},{"issue":"01","key":"ref59","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1054\/blre.2001.0170","article-title":"Humanized mouse models of FcR clearance in immune platelet disorders","volume":"16","author":"S E McKenzie","year":"2002","journal-title":"Blood Rev"},{"issue":"07","key":"ref60","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.4049\/jimmunol.162.7.4311","article-title":"The role of the human Fc receptor Fc gamma RIIA in the immune clearance of platelets: a transgenic mouse model","volume":"162","author":"S E McKenzie","year":"1999","journal-title":"J Immunol"},{"issue":"10","key":"ref61","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1182\/blood-2002-05-1307","article-title":"Identification of distal regulatory regions in the human \u03b1 IIb gene locus necessary for consistent, high-level megakaryocyte expression","volume":"100","author":"M A Thornton","year":"2002","journal-title":"Blood"},{"issue":"10","key":"ref62","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood-2003-11-3994","article-title":"Transgenic mice studies demonstrate a role for platelet factor 4 in thrombosis: dissociation between anticoagulant and antithrombotic effect of heparin","volume":"104","author":"D E Eslin","year":"2004","journal-title":"Blood"},{"issue":"05","key":"ref63","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00062752-200209000-00002","article-title":"Insights from mouse models of heparin-induced thrombocytopenia and thrombosis","volume":"9","author":"M P Reilly","year":"2002","journal-title":"Curr Opin Hematol"},{"issue":"15","key":"ref64","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1182\/bloodadvances.2023009661","article-title":"Treatment of thrombocytopenia and thrombosis in HIT in mice using deglycosylated KKO: a novel therapeutic?","volume":"7","author":"A Sarkar","year":"2023","journal-title":"Blood Adv"},{"issue":"10","key":"ref65","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1111\/jth.13786","article-title":"5B9, a monoclonal antiplatelet factor 4\/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies","volume":"15","author":"C Kizlik-Masson","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"03","key":"ref66","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1172\/JCI90958","article-title":"Endothelial antigen assembly leads to thrombotic complications in heparin-induced thrombocytopenia","volume":"127","author":"V Hayes","year":"2017","journal-title":"J Clin Invest"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1055\/s-0045-1814645","article-title":"Novel humanized mouse model of heparin-induced thrombocytopenia","volume":"46","author":"N Risio","year":"2026","journal-title":"H\u00e4mostaseologie"},{"issue":"07","key":"ref69","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJMoa2514824","article-title":"Adenoviral inciting antigen and somatic hypermutation in VITT","volume":"394","author":"J J Wang","year":"2026","journal-title":"N Engl J Med"},{"issue":"06","key":"ref70","doi-asserted-by":"crossref","first-page":"e1295","DOI":"10.1002\/cti2.1295","article-title":"Next-generation Bruton's tyrosine kinase inhibitor BIIB091 selectively and potently inhibits B cell and Fc receptor signaling and downstream functions in B cells and myeloid cells","volume":"10","author":"E Bame","year":"2021","journal-title":"Clin Transl Immunology"},{"issue":"23","key":"ref71","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1182\/blood-2010-03-276964","article-title":"Monocyte-bound PF4 in the pathogenesis of heparin-induced thrombocytopenia","volume":"116","author":"L Rauova","year":"2010","journal-title":"Blood"},{"issue":"03","key":"ref72","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1538-7836.2011.04615.x","article-title":"In vivo monitoring of venous thrombosis in mice","volume":"10","author":"M N Aghourian","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"05","key":"ref73","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1538-7836.2009.03330.x","article-title":"Optimization of a murine immunization model for study of PF4\/heparin antibodies","volume":"7","author":"S Suvarna","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"17","key":"ref74","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM200104263441704","article-title":"Temporal aspects of heparin-induced thrombocytopenia","volume":"344","author":"T E Warkentin","year":"2001","journal-title":"N Engl J Med"},{"issue":"17","key":"ref75","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2013-01-477091","article-title":"Critical role for mouse marginal zone B cells in PF4\/heparin antibody production","volume":"121","author":"Y Zheng","year":"2013","journal-title":"Blood"},{"issue":"04","key":"ref76","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1365-2141.2008.07240.x","article-title":"Platelet factor 4-heparin complexes trigger immune responses independently of the MyD88 pathway","volume":"142","author":"S Suvarna","year":"2008","journal-title":"Br J Haematol"},{"issue":"04","key":"ref77","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1160\/TH15-08-0654","article-title":"Further insights into the anti-PF4\/heparin IgM immune response","volume":"115","author":"K Krauel","year":"2016","journal-title":"Thromb Haemost"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1055\/a-2736-5418","article-title":"Free nucleic acids in the ChAdOx1 nCov-19-S adenovirus vector vaccine contribute to an anti-platelet factor 4 antibody response","author":"F Siegerist","year":"2025","journal-title":"Thromb Haemost"},{"issue":"05","key":"ref79","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1182\/blood.2021014712","article-title":"Thrombocytopenia and splenic platelet-directed immune responses after IV ChAdOx1 nCov-19 administration","volume":"140","author":"L Nicolai","year":"2022","journal-title":"Blood"},{"issue":"07","key":"ref80","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1073\/pnas.94.7.3352","article-title":"HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses","volume":"94","author":"R P Tomko","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"ref81","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.3324\/haematol.2021.279289","article-title":"Interactions of adenoviruses with platelets and coagulation and the vaccine-induced immune thrombotic thrombocytopenia syndrome","volume":"106","author":"P Gresele","year":"2021","journal-title":"Haematologica"},{"issue":"09","key":"ref82","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1182\/blood-2009-07-231506","article-title":"The severity of trauma determines the immune response to PF4\/heparin and the frequency of heparin-induced thrombocytopenia","volume":"115","author":"N Lubenow","year":"2010","journal-title":"Blood"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2870-6827.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T23:14:00Z","timestamp":1782170040000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2870-6827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":81,"URL":"https:\/\/doi.org\/10.1055\/a-2870-6827","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6,15]]},"published":{"date-parts":[[2026,6,15]]}}}